Laurus Labs Ltd IPO (Laurus Labs IPO) Detail

Dec 6, 2016 - Dec 8, 2016

Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.

Laurus Labs operates in four business lines:
1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.
2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.
3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.
4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.

Key Highlights:
1. Laurus Labs launched 59 products since our inception in 2005.
2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.
3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.
4. The Company owned 32 patents and had 150 pending patent applications, in several countries.
5. Company has three manufacturing facilities in Visakhapatnam, Andhra Pradesh.
6. Company sells its products in 32 countries in Sub-Saharan Africa, South-East Asia and Latin America.

Key Strengths:
1. Leadership in APIs in Select, High Growth Therapeutic Areas
2. Strong R&D Capabilities and Process Chemistry Skills
3. Industry Leading, Modern and Regulatory Compliant Manufacturing Capacities
4. Long-standing Relationships with Multi-National Pharmaceutical Companies
5. Experienced Promoters and Qualified Operational Personnel
6. Established Track Record of Delivering Growth

Company Promoters:

The Promoters of the company are:

1. Dr Satyanarayana Chava
2. Naga Rani Chava
3. Dr Raju Srihari Kalidindi
4. Ravi Kumar V V and
5. Dr Lakshmana Rao C V

Company Financials:

Summary of financial Information
Particulars	For the year/period ended (in Rs. Million)
	31-Mar-16	31-Mar-15	31-Mar-14	31-Mar-13	31-Mar-12
Total Assets	23,083.48	18,925.49	12,730.58	7,009.89	5,128.78
Total Revenue	17,884.15	13,603.80	11,685.34	7,235.67	4,523.07
Profit After Tax (PAT)	1,435.68	735.17	972.17	882.19	215.77

Objects of the Issue:

The object of the issue are to:
1. Pre-payment of term loans; and
2. General corporate purposes.

Laurus Labs IPO Details

Issue Open	Dec 6, 2016 - Dec 8, 2016
Issue Type	Book Built Issue IPO
Issue Size	31,116,785 Eq Shares of Rs 10 (aggregating up to Rs 1,331.80 Cr)
Fresh Issue	7,009,345 Eq Shares of Rs 10 (aggregating up to Rs 300.00 Cr)
Offer for Sale	24,107,440 Eq Shares of Rs 10 (aggregating up to Rs 1,031.80 Cr)
Face Value	Rs 10 Per Equity Share
Issue Price	Rs 426 - Rs 428 Per Equity Share
Market Lot	35 Shares
Min Order Quantity	35 Shares
Listing At	BSE, NSE

Laurus Labs IPO Tentative Date / Timetable

Bid/Offer Opens On	Dec 6, 2016
Bid/Offer Closes On	Dec 8, 2016
Finalisation of Basis of Allotment	Dec 14, 2016
Initiation of Refunds	Dec 15, 2016
Credit of Shares to Demat Acct:	Dec 16, 2016
IPO Shares Listing Date:	Dec 19, 2016

Laurus Labs IPO Subscription Status (Bidding Detail)

Laurus Labs IPO how much subscribed?
	No. of Times Issue Subscribed (BSE + NSE)
As on Date & Time	QIB	NII	RII	Employee	Total
Shares Offered	6,174,544	4,623,879	10,789,051	323,834	21,911,308
Dec 8, 2016 18:18	10.54x	3.57x	1.58x	1.71x	4.53x

Laurus Labs IPO Prospectus

› Draft Prospectus
› Red Herring Prospectus

Laurus Labs IPO Rating

774

4.2

Rating:

Vote Here ...

Laurus Labs IPO Listing Date

Listing Date	Monday, December 19, 2016
BSE Script Code	540222
NSE Symbol	LAURUSLABS
Listing In	B
ISIN	INE947Q01010
Issue Price	Rs 428 Per Equity Share
Face Value	Rs 10 Per Equity Share

Listing Day Trading Information

.
Issue Price
Open
Low
High
Last Trade
Volume

BSE
Rs 428.00
Rs 490.00
Rs 475.00
Rs 498.00
Rs 480.50
3,952,346

NSE
Rs 428.00
Rs 489.90
Rs 475.00
Rs 498.00
Rs 480.40
17,548,335

Laurus Labs IPO Reviews / Ratings

Capital Market Review
Ajcon Global - Subscribe.
KRChoksey - Subscribe.
HEM Securities - Avoid.
Dilip Davda - Subscribe

Company Contact Information

Laurus Labs Ltd
Plot No.21,
Jawaharlal Nehru Pharma City,
Parawada, Visakhapatnam 531 021

Phone: + 91 40 3980 4333
Email: secretarial@lauruslabs.com
Website: http://www.lauruslabs.com

Laurus Labs IPO Registrar

Karvy Computershare Private Limited
   Karvy Registry House, 8-2-596, St. No. 1,
   Banjara Hills, Hyderabad - 500 034
   Andhra Pradesh, India

Phone: +91-40-23312454
Email: einward.ris@karvy.com
Website: https://karisma.karvy.com/

Laurus Labs IPO Lead Manager(s)

Lead Manager Reports

Guaranteed Save 60% to 90% Brokerage

You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...

Find Laurus Labs IPO Latest Update

Useful Articles

Laurus Labs IPO Review / Comments

1304. Hardik Chudgar Feb 21, 2017 14:10

Laurus jumps around 518. Should wait or exit??

1303. nona Feb 21, 2017 11:52

gamble ji

lauras lab kab jagega

thank u

1302. A patel..Gujarat.. Feb 16, 2017 12:24

1 |

Laurus exit tatget 428..few days..exit.. issue prise coming up..

1301. rvr Feb 16, 2017 08:14

1 |

IPO Mentor (600+ Posts, 600+ Likes)

laurus will sail to 580 shortly

1300. rvr Feb 16, 2017 08:14

1 |

IPO Mentor (600+ Posts, 600+ Likes)

LAURUS will reach 580 in 2 days...

1299. A patel..Gujarat.. Feb 15, 2017 13:58

1 |

Exit laurus lab. And Buy Sun farma...Best Retun in Short time..

1298. NPT Feb 10, 2017 19:01

Top Contributor (200+ Posts, 300+ Likes)

I have positive outlook on Laurus Labs for the 4th quarter result because company will be benefitted from operation of its new unit which started production in Nov 2016. The company is expected to get some parents during the quarter. Company bottom line will improve because of payment of debts to the tune of R''s.226 crores from the ipo proceeds. There is a chance that in the short run it may test R''s.480 level again.

1298.1. AKH Feb 11, 2017 12:35

IPO Mentor (800+ Posts, 700+ Likes)

The company is expected to get "Some Parents" what is this ?

1298.2. NPT Feb 11, 2017 15:24

Top Contributor (200+ Posts, 300+ Likes)

It is a typing mistake. It is patent, not parents.

1297. CLD Feb 10, 2017 11:12

IPO Mentor (500+ Posts, 100+ Likes)

No body is answering the question of people about selling or holding of the shares they are holding. I have already got my whats up group members to book part profits yesterday at 560. I don''t know why people are not helping others. No body is expert in market still experienced people can give suggestions. My previous posts can be seen by clicking on my name.

Load more comments (2 replies)

1297.3. Shivajee Feb 16, 2017 06:47

1 |

IPO Mentor (700+ Posts, 100+ Likes)

I like this post by CLD. True. But gamble is very helpful, he responds to questions by the inexperienced.

Nobody says how they became experts also. It is better to teach people how to catch fish rather than catching them, cooking and then feeding to people.

1297.4. nona Feb 16, 2017 11:00

2 |

shivajee sir

I do agree with YOU

1296. gamble Feb 10, 2017 08:20

IPO Guru (1600+ Posts, 3900+ Likes)

Avg. set of numbers.
...stock already priced in this type of no.s

1295. VALUE INVESTOR Feb 10, 2017 03:48

IPO Mentor (800+ Posts, 500+ Likes)

http://www.moneycontrol.com/news/results/laurus-labs-net-profit175-to-rs472-croreq3_8465141.html

Laurus Laboratories posted a 17.5 percent increase in net profit to Rs 47.2 crore in the third quarter ended December on account of larger uptake of its API business.

1295.1. Cbm Feb 10, 2017 10:10

Experts,
kindly let me you views about Laurus Lab
whether it sell or hold

1295.2. AKH Feb 10, 2017 15:51

IPO Mentor (800+ Posts, 700+ Likes)

@CBM
Actually experts dont reply. My opinion is to hold till results of next quarter, if you can

1294. Umang & his ultrasonic uproar Feb 9, 2017 18:58

Laurus labs result is out... Pls see on bse site(corporate announcements). Pls analyze Mr Septa, Mr gamble and help us understand weather it is good or not

1294.1. NPT Feb 9, 2017 20:13

1 |

Top Contributor (200+ Posts, 300+ Likes)

One more positive note in the result is that its total revenue and pat for December 16 quarter has increased in comparison to the December 2015 quarter''s results.

1294.2. VALUE INVESTOR Feb 9, 2017 20:30

IPO Mentor (800+ Posts, 500+ Likes)

Let''s see how market react tomorrow.

1293. Chem cho Feb 8, 2017 16:57

IPO Guru (1800+ Posts, 1600+ Likes)

Laurus was trading between 475 to 480 from jan 17 from 3 feb movement was seen in this script now it has risen to high of RS 585 and todays low of Rs 546

script is worth holding at ipo price those who got allotment for better target than Rs 600

1292. deepika Feb 7, 2017 14:52

1 |

LAURUS LAB

TARGET 600-650 FEB MONTH 100%

1292.1. AJ''s Actions Feb 7, 2017 17:29

Is this true news?

1292.2. rvr Feb 8, 2017 20:01

IPO Mentor (600+ Posts, 600+ Likes)

in market nothing is true....only predictions..

1291. deepika Feb 7, 2017 14:52

LAURUS LAB

TARGET 600-650 FEB MONTH 100%

1290. deepika Feb 7, 2017 14:18

KINDLY BUY LAURUS

TARGET 590 ONLY 2 DAYS

1289. A patel..Gujarat.. Feb 7, 2017 12:51

2 lot sold. 583.70...

1288. CA M&co.Jodhpur Feb 7, 2017 10:30

1 |

Sell Laurus lab and buy Alkem Lab for best return in this year.
Alkem lab near 52week high very strong fundamental strong pharmaceutical company.

1288.1. CA M&co.Jodhpur Feb 13, 2017 11:54

1 |

My expectations is correct.see Alkem Lab at new 52 week high.and laurus down.
Buy Alkem Lab instead of Lauruse lab.

1287. s.selvam Feb 6, 2017 20:23

Though I have not been allotted in BSE IPO I have been allotted LAURUS LAB AND IT TESTED MY PATIENCE FOR QUITE A LONG TIME.IT OSCILATES AROUND RS.472/- TO RS.480/- FOR QUITE A LONG TIME.EAGLE EYE MADAM I THANK U AFTER SEEING YOUR MESSAGE TO HOLD. I HAVE NOT SOLD THOSE SHARES.NOW I AM REACHING THE BENEFITS.LATER ONLY I KNOW THAT THEY ARE ONE OF API OF MEDICINES FOR ONCOLOGY AND HEPATITIS.I THANK ONCE AGAIN EAGLE EYE MADAM I AM HOLDING 70 SHARES OF LL WHICH I WILL GIFT IT TO MY GRAND DAUGHTER AND GRAND SON..

1286. CA Bhaumik Shah Feb 6, 2017 17:39

Dear Eagleye

What will be the next target ?
Whether it may go to 650 to 700 ?

1285. Eagleye Feb 6, 2017 12:54

9 |

IPO Guru (4800+ Posts, 15300+ Likes)

Laurus ðŸš€ðŸš€ðŸš€

Load more comments (3 replies)

1285.4. NPT Feb 6, 2017 21:15

Top Contributor (200+ Posts, 300+ Likes)

Laurus will fire like Agni5000. For this reason we have to wait and watch its next two Quarters'' result. If during this period its result continues to show the recent past growth rate and if it receives a couple of patent in the meantime, it will be another Glenmark.

1285.5. Shivajee Feb 7, 2017 07:48

IPO Mentor (700+ Posts, 100+ Likes)

People were so praising of Adv Enzymes like Laurus labs. But it came down to 1800 levels.

We should look at "on what basis it will shoot like agni or rocket" really.

Name		Phone
Email		City
State
Are you a day trader?